Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market

Q4 fiscal 2026. Management View "Total revenues for the year were $149 million" and Elite delivered "operating income was $49 ...

Elite Pharmaceuticals, Inc. (ELTP) Q4 2026 Earnings Call Transcript

Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Year-End Fiscal Year 2026 Conference Call. [Operator Instructions]. Before management begins speaking, the conference has ...